Repligen (RGEN) Capital Expenditures Growth (1y) (2011 - 2026)
Repligen (RGEN) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.11 Bn | 121.89 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.95 Bn | 44.14 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | - |
| 4 | Medline | 32.85 Bn | 30.61 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.33 Bn | 22.89 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.83 Bn | 13.69 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | 21.73% |
| 10 | Repligen | 7.46 Bn | 6.47 Bn | 108.28 Mn | -72.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.66% |
| Dec 31, 2025 | 102.35% |
| Sep 30, 2025 | -99.12% |
| Jun 30, 2025 | 1,645.45% |
| Mar 31, 2025 | 370.94% |
| Dec 31, 2024 | 7.87% |
| Sep 30, 2024 | 144.47% |
| Jun 30, 2024 | -100.53% |
| Mar 31, 2024 | -103.76% |
| Dec 31, 2023 | -2,469.60% |
| Sep 30, 2023 | 1,110.10% |
| Jun 30, 2023 | 871.70% |
| Mar 31, 2023 | 728.53% |
| Dec 31, 2022 | 103.07% |
| Sep 30, 2022 | -97.89% |
| Jun 30, 2022 | 115.72% |
| Mar 31, 2022 | -86.46% |
| Dec 31, 2021 | -370.30% |
| Sep 30, 2021 | 270.75% |
| Jun 30, 2021 | -183.84% |